Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial

  1. Cortes, J.E.
  2. Gambacorti-Passerini, C.
  3. Deininger, M.W.
  4. Mauro, M.J.
  5. Chuah, C.
  6. Kim, D.-W.
  7. Dyagil, I.
  8. Glushko, N.
  9. Milojkovic, D.
  10. Le Coutre, P.
  11. Garcia-Gutierrez, V.
  12. Reilly, L.
  13. Jeynes-Ellis, A.
  14. Leip, E.
  15. Bardy-Bouxin, N.
  16. Hochhaus, A.
  17. Brümmendorf, T.H.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2018

Alea: 36

Zenbakia: 3

Orrialdeak: 231-237

Mota: Artikulua

DOI: 10.1200/JCO.2017.74.7162 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus